146 related articles for article (PubMed ID: 2443540)
21. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
[TBL] [Abstract][Full Text] [Related]
22. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
Eckels DD; Sell TW; Long EO; Sekaly RP
Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
[TBL] [Abstract][Full Text] [Related]
23. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
[TBL] [Abstract][Full Text] [Related]
24. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
25. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. III. Family segregation analyses.
Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
Immunogenetics; 1988; 27(1):31-9. PubMed ID: 3257098
[TBL] [Abstract][Full Text] [Related]
26. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
Letarte M; Addis J; Iturbe S; Petsche D
Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
[TBL] [Abstract][Full Text] [Related]
27. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
[TBL] [Abstract][Full Text] [Related]
28. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
29. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
[TBL] [Abstract][Full Text] [Related]
30. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain.
Merryman P; Silver J; Gregersen PK; Solomon G; Winchester R
J Immunol; 1989 Sep; 143(6):2068-73. PubMed ID: 2476494
[TBL] [Abstract][Full Text] [Related]
31. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
[TBL] [Abstract][Full Text] [Related]
32. Apparent HLA DR triplet due to the coexpression of a DRB5-encoded molecule on a DR1 haplotype.
Gebuhrer L; Tiercy JM; Freidel AC; Labonne MP; Lambert J; Jeannet M; Betuel H
Hum Immunol; 1992 Jun; 34(2):91-8. PubMed ID: 1429037
[TBL] [Abstract][Full Text] [Related]
33. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
[TBL] [Abstract][Full Text] [Related]
34. N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens.
Walker LE; Hewick R; Hunkapiller MW; Hood LE; Dreyer WJ; Reisfeld RA
Biochemistry; 1983 Jan; 22(1):185-8. PubMed ID: 6600932
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
36. [HLA antigens and different clinical forms of 21-hydroxylase deficiency in the French population].
Couillin P; Ravisé N; Hors J; Feingold J; Rappaport R; Kuttenn F; Boué A
Pathol Biol (Paris); 1986 Jun; 34(6):789-94. PubMed ID: 3531997
[TBL] [Abstract][Full Text] [Related]
37. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
Roche PA; Cresswell P
J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
[TBL] [Abstract][Full Text] [Related]
38. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
Weyand CM; Hicok KC; Goronzy JJ
J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
[TBL] [Abstract][Full Text] [Related]
39. Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
Davis JE; Cook RG; Brown MF; Pollack MS; Van M; Rich RR
Transplant Proc; 1987 Feb; 19(1 Pt 1):851-7. PubMed ID: 3493566
[No Abstract] [Full Text] [Related]
40. Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition.
Weyand CM; Goronzy JJ
J Clin Invest; 1990 Apr; 85(4):1051-7. PubMed ID: 1690755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
